Intraperitoneal atomization of levobupivacaine during gynecological laparoscopic procedures : Impact on pain, opioid use and length of recovery room stay (IPLA).
Phase 1
- Conditions
- Patients who are planned for gynecological laparoscopic interventions on an ambulatory basis.MedDRA version: 14.1Level: LLTClassification code 10002182Term: AnalgesiaSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2013-000384-87-BE
- Lead Sponsor
- Ghent University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
- Patients who are planned for gynecological laparoscopic interventions on an ambulatory basis.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Less than 18 year old
- Weight less than 50 kg and more than 80 kg
- Pregnant
- Prisoners
- Allergic to topical anesthetics (Amides specifically)
- Allergic to Opioids as a class
- Currently or within the last 30 days been prescribed an opiate medication
- Chronic pain syndrome
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method